一种新的综合整合和结合元素调解了从Streptococcus anginosus到Streptococcus agalactiae的多种药物耐药性
Yingting Wang1, Taoran Liu1, Sida Yi2
1Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
Infection and drug resistance
|April 23, 2025
概括
在Streptococcus anginosus中发现了一种新的整合和结合元件 (ICE),ICESan26_rplL,携带多个抗生素耐药性基因. 这种ICE证明了对Streptococcus agalactiae的可转移性,突出了它在传播抗菌素耐药性的潜在作用.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 整合性和结合性元素 (ICE) 是移动基因元素,对于水平基因转移至关重要.
- ICEs在细菌群体中对抗菌素耐药性 (AMR) 的传播有显著的贡献,特别是在Streptococci中.
研究的目的:
- 为了识别和表征一种来自共生性Streptococcus anginosus的新型ICE.
- 调查小说ICE的遗传结构,切除和跨物种的可转移性.
- 评估这种ICE在调解抗生素耐药性基因传播方面的潜力.
主要方法:
- 用于ICE识别的生物信息分析.
- 进行比较基因组学以描述ICE结构.
- 逆PCR来确认染色体切除和循环化.
- 结合实验,以评估物种间的可转移性.
- 测序以验证成功的传输.
主要成果:
- 一种新的61.6kB的ICE,ICESan26rplL,在S.S.的下游被发现. 痛性 痛性 痛性
- ICESan26_rplL携带多个抗生素耐药性基因,包括erm(B),tetM-tetL,lnu,lsa(E),和ant(6) -I.
- ICE证明了成功切除和跨物种转移到Streptococcus agalactiae的频率为2.13 × 10-8.
- 对比分析显示,一个由ICESa2603和TnGBS家族的模块组成的马赛克结构.
结论:
- ICESan26_rplL代表了一种新的马赛克ICE,对AMR传播有重大影响.
- 已证明的对病原体的转移性S. agalactiae强调其作为传播多药耐药性的载体的潜力.
- 这一发现强调了监测开始性细菌中的ICE的重要性,以了解和控制链球菌中的AMR传播.
关键词:
ICEs是什么意思链球菌的 agalactiaeae 是一个细菌.这种病原菌是Streptococcus anginosusus.抗生素耐药性基因是抗生素耐药性的基因.这是一个复合材料.结合转移转移 结合转移更多相关视频
08:21Site-specific Bacterial Chromosome Engineering: ΦC31 Integrase Mediated Cassette Exchange (IMCE)
Published on: March 16, 2012
15.5K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
488
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:27Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
01:06Carrier-Mediated Transport
212
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
212
00:57Antibiotic Selection
51.9K
Overview
51.9K
01:14Phase II Conjugation Reactions: Overview
110
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
110
01:33Bacterial Transformation
54.9K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
54.9K